Results 131 to 140 of about 15,163 (213)

Common on “Plateletpheresis for treating essential thrombocythemia that developed during pregnancy: A case report”

Taiwanese Journal of Obstetrics & Gynecology
Wenyou Zhao, Jianguo Pei
doaj   +1 more source

Driver mutation-defined molecular landscapes of essential thrombocythemia. [PDF]

Blood Sci
Lorenzen AL, Huang G.
europepmc   +1 more source

Recurrent central retinal artery occlusion as the initial manifestation of essential thrombocythemia: A case report. [PDF]

Medicine (Baltimore)
Chen M, Du C, Lan H, Liu J.
europepmc   +1 more source

Myelofibrotic transformation in essential thrombocythemia

Haematologica, 2009
Juergen Thiele, Hans Michael Kvasnicka
doaj   +1 more source

Ruxolitinib reverses systemic vasculitis driven by JAK2 V617F-mutated essential thrombocythemia: a case report. [PDF]

Front Immunol
Ashida Y, Ota S, Ishidoya N, Murai Y, Amenomori K, Hasui K, Kawaguchi S, Yamaguchi S, Hiraga H, Kamata K, Ichikawa H, Tomita H, Yu Z, Minakawa M, Sakuraba H.   +14 more
europepmc   +1 more source

Novel strategies targeting mutant calreticulin in essential thrombocythemia and myelofibrosis. [PDF]

Blood
Salzman GS, Mullally A.
europepmc   +1 more source

Impact of thrombosis on disease progression, cancer and mortality in patients with essential thrombocythemia and polycythemia vera. [PDF]

Blood Cancer J
Angona A, Cuevas B, Pérez-Encinas M, Ferrer-Marin F, Senín A, Arellano-Rodrigo E, Hernández-Boluda JC, Mata Vázquez MI, Caballero-Navarro G, Gómez-Casares MT, Magro E, Carreño-Tarragona G, Cortés-Vázquez MA, Pérez López R, García-Gutiérrez V, Noya-Pereira MS, Alonso-Dominguez JM, Sierra-Aisa C, Fox L, García Hernández C, Guerra JM, Cerezo E, Gasior M, Santaliestra M, Díez I, Cuevas MV, Sanz L, Pastor I, Stuckey R, Vélez P, Auría-Caballero C, Alvarez-Larrán A.   +31 more
europepmc   +1 more source

Response to therapy and prognosis according to molecular characterization in <i>CALR</i>-mutated essential thrombocythemia. [PDF]

Hemasphere
Santaliestra M, Garrote M, Fernández-Rodríguez MC, Vélez P, Senín A, Arellano-Rodrigo E, Garcia-Gisbert N, Longarón R, Pérez-Encinas M, Caballero-Navarro G, Noya-Pereira MS, Cuevas B, Gómez-Casares MT, Stuckey R, Carreño-Tarragona G, Ferrer-Marin F, Cortés MA, Magro E, Mata I, Angona A, Pérez R, Fox ML, Pastor-Galán I, Sastre P, Triguero A, García-Gutierrez V, Hernández-Boluda JC, Bellosillo B, Alvarez-Larran A.   +28 more
europepmc   +1 more source

Physiological MplW514L expression in hematopoietic stem cell causes an essential thrombocythemia and progressive myelofibrosis. [PDF]

J Clin Invest
Zhang S, Liu J, Li Y, Wang Y, Wang L, Xu M, Li Y, Dong G, Wang S, Li Y, Cai Z, Zhao B.   +11 more
europepmc   +1 more source

Phase 2 study of the lysine-specific demethylase 1 inhibitor bomedemstat for essential thrombocythemia. [PDF]

Blood Adv
Gill H, Palandri F, Ross DM, Göthert JR, Cochrane T, Larsen SR, Halpern AB, Shortt J, Rossetti JM, Liang J, Marchetti M, Wilson AJ, Innes AJ, Hanna M, Vianelli N, Stevenson WS, Vannucchi AM, Kleppe M, Flynn J, Natsoulis G, Harrison CN, Rienhoff HY.   +21 more
europepmc   +1 more source